Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus

Annals of the New York Academy of Sciences

Volumn 928, Issue , 2001, Pages 200-211

  Yoon, Ji Won ^a,b,c   Jun, Hee Sook ^a,b  

^a Department of Microbiology and Infectious Disease ^*  (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Autoimmune diseases; Diabetes mellitus, insulin dependent; IDDM; Insulin dependent diabetes mellitus

Indexed keywords

AUTOANTIGEN; FAS LIGAND; GLUTAMATE DECARBOXYLASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0035041407     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb05650.x     Document Type: Conference Paper

References (52)

1. Insulin-dependent diabetes mellitus
2. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency
3. Antibodies to pancreatic islet cells in insulin-dependent diabetes with coexistent autoimmune disease
4. Insulin-dependent diabetes mellitus as a β cells targeted disease of immunoregulation
5. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
6. Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat
7. 67 in human, rat, and mouse pancreatic islets
8. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
9. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice
10. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice
11. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide
12. Widespread expression of an autoantigen GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease
13. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells
14. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells
15. Suppression of diabetes in non obese diabetic mice by oral administration of porcine insulin
16. Insulin-dependent diabetes mellitus and its animal models
17. Epitope specificity cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from the NOD mouse
18. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
19. Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice
20. Imogen 38: A novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type I diabetic patient
21. Studies on autoimmunity for initiation of beta-cell destruction. VIII. Pancreatic beta cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats
22. Human pancreatic islet cell-specific 38kD autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody
23. Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies
24. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity
25. Cellular and molecular mechanisms for the initiation and progression of β-cell destruction resulting from the collaboration between macrophages and T cells
26. Prospective analysis of islet lesions in BB rats
27. Role of macrophages in T cell-mediated autoimmune diabetes in NOD mice
28. + T cells in T-cell receptor transgenic NOD mice
29. Human tumor-necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta cell-cytotoxicity
30. Spontaneous cytotoxicity of macrophages against pancreatic islet cells
31. Does nitric oxide mediate autoimmune destruction of β cells? Possible therapeutic interventions in IDDM
32. null mice
33. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice
34. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice
35. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat
36. Prevention of diabetes in Biobreeding/Worcester rats with monoclonal antibodies that recognize T-lymphocytes or natural killer cells
37. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice
38. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background
39. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes
40. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NON-Thy-1a donors
41. + T cells
42. + islet-specific T cell clone
43. Following a diabetogenic T cell from genesis through pathogenesis
44. + T cell clones derived from lymphocytes infiltrating the islets of NOD mice
45. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells
46. Acceleration of diabetes in TCR-β-transgenic nonobese diabetic mice by beta cell-cytotoxic T cells expressing endogenous TCR-α chains
47. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice
48. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
49. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
50. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice
51. Significant role for fas in the pathogenesis of autoimmune diabetes
52. Beta cell apoptosis in T cell-mediated autoimmune diabetes